fluoxetine has been researched along with alpha-synuclein in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barlow, C; Carter, T; Kohl, Z; Mante, M; Masliah, E; Münch, M; Rockenstein, E; Ubhi, K; Winkler, J; Winner, B | 1 |
| Adame, A; Inglis, C; Mante, M; Masliah, E; May, V; Patrick, C; Rockenstein, E; Spencer, B; Ubhi, K; Winkler, J | 1 |
2 other study(ies) available for fluoxetine and alpha-synuclein
| Article | Year |
|---|---|
Fluoxetine rescues impaired hippocampal neurogenesis in a transgenic A53T synuclein mouse model.
Topics: Adult; alpha-Synuclein; Animals; Brain-Derived Neurotrophic Factor; Cell Proliferation; Disease Models, Animal; Fluoxetine; Glial Cell Line-Derived Neurotrophic Factor; Hippocampus; Humans; Mice; Mice, Transgenic; Neurogenesis; Parkinson Disease; Proliferating Cell Nuclear Antigen; Selective Serotonin Reuptake Inhibitors; Stem Cells; Transgenes | 2012 |
Fluoxetine ameliorates behavioral and neuropathological deficits in a transgenic model mouse of α-synucleinopathy.
Topics: alpha-Synuclein; Animals; Behavior, Animal; Brain; Fluoxetine; Glial Cell Line-Derived Neurotrophic Factor; Mice; Mice, Transgenic; Motor Skills; Nerve Degeneration; Neurons; Selective Serotonin Reuptake Inhibitors | 2012 |